Crus

Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.

Retrieved on: 
Thursday, November 2, 2023
Science, Pharmacology, CGMP, Clinical pharmacology, CRU, Physician, Crus, Research, Volunteering, Cras, Facility, Pharmacy, GMP, Safety, Investment, Nursing, Patient, Pharmaceutical industry

“Our integrated platform of services includes best-in-class infrastructure and experienced professionals who are fully dedicated to clinical pharmacology, including physicians, nurses, clinical scientists, CRAs and pharmacokineticists.

Key Points: 
  • “Our integrated platform of services includes best-in-class infrastructure and experienced professionals who are fully dedicated to clinical pharmacology, including physicians, nurses, clinical scientists, CRAs and pharmacokineticists.
  • Improvements in recreational, living and “work-from-home” spaces at Fortrea CRUs have been constructed to enhance the experience of volunteers participating in research at the sites.
  • The expansion of Fortrea’s early clinical development pharmacy services facilities includes new state-of-the-art cGMP pharmacies in the Leeds and Daytona CRUs.
  • “I believe Fortrea’s early clinical development solutions set a new standard for what the research industry should expect from its partners,” said Dr. Cohen.

Stratus Unveils Evolutionary Fault Tolerance with ztC Endurance Family of Intelligent, Predictive Computing Platforms

Retrieved on: 
Wednesday, November 1, 2023
Software, Networks, Data Analytics, Artificial Intelligence, Data Management, Professional Services, Technology, Mobile, Wireless, DDR5, OT, Architecture, IDC, Organization, SGH, Crus, NVM Express, Xeon, Multimedia, Intel, Plant, Edge computing, Central Bank of India, TIGA, Automation, Failure, Video game, Cryptocurrency, Stratus

Stratus Technologies, Inc. (“Stratus”) , an SGH (Nasdaq: SGH ) company and a global leader in simple, protected, and autonomous Edge Computing platforms, today announced the launch of its Stratus ztC Endurance™ platform , a new family of fault-tolerant computing platforms for next-generation sustainable operations.

Key Points: 
  • Stratus Technologies, Inc. (“Stratus”) , an SGH (Nasdaq: SGH ) company and a global leader in simple, protected, and autonomous Edge Computing platforms, today announced the launch of its Stratus ztC Endurance™ platform , a new family of fault-tolerant computing platforms for next-generation sustainable operations.
  • View the full release here: https://www.businesswire.com/news/home/20231101435012/en/
    Stratus’ ztC Endurance platform is the new generation of zero-touch computing platforms that delivers breakthrough 99.99999% availability and increased serviceability and manageability.
  • Stratus’ ztC Endurance portfolio furthers Stratus’ proven approach for eliminating system downtime and data loss (including in-flight data) through built-in fault tolerance that is transparent to standard operating systems and hosted applications.
  • Additionally, the ztC Endurance platform and its fault tolerant architecture support standard, off-the-shelf operating systems without requiring modifications.

Evolution Research Group, LLC Establishes Internal Continuing Medical Education (CME) Program - Partners with University of Miami, Miller School of Medicine

Retrieved on: 
Wednesday, November 16, 2022
Crus, CRO, MD, Licensure, Anesthesiology, Scientific Leadership, Knowledge, Chronic pain, NEW, Physician, Volunteering, SLT, University, Industry, View, Multimedia, Program, ERG, Patient, Principal, CME, Division, Neuroscience, LLC, Drug, Psychiatry, Continuing medical education, Sleep, Pharmaceutical industry

The development of this program was derived from ERG's Scientific Leadership team (SLT).

Key Points: 
  • The development of this program was derived from ERG's Scientific Leadership team (SLT).
  • The SLT is comprised of internal and external industry experts across all therapeutic areas in which the organization focuses.
  • "In today's busy research environment, physician Investigators and clinicians are hard pressed to find the time to meet licensure requirements for continuing education.
  • Evolution Research Group, LLC is a subsidiary of ERG Holding Company, which includes twenty owned and operated CRUs,an established network of affiliated clinical research sites, Lotus Clinical Research, LLC, a full-service CRO, and CNS Ratings, LLC.

NEXII OPENS FIRST PLANT IN U.S. MANUFACTURING BREAKTHROUGH SUSTAINABLE CONSTRUCTION PRODUCTS AND TECHNOLOGY

Retrieved on: 
Tuesday, February 8, 2022
Coal, LCA, NCM, Steel, Multimedia, Face, Crus, CEO, Climate change, Building material, Carbon, Plant, LLC, Renewable energy

HAZLETON, Pa., Feb. 8, 2022 /PRNewswire/ -- Nexii Building Solutions (Nexii), a Canada-based green construction technology company, announces the opening of its first U.S. plant today in Hazleton, Pennsylvania.

Key Points: 
  • HAZLETON, Pa., Feb. 8, 2022 /PRNewswire/ -- Nexii Building Solutions (Nexii), a Canada-based green construction technology company, announces the opening of its first U.S. plant today in Hazleton, Pennsylvania.
  • Due to the high demand for green building products, Nexii also works with licensees, called Nexii Certified Manufacturers (NCMs), to develop and operate additional plants across the U.S. and Canada.
  • This supports rapid expansion and supply of sustainable building products, while creating green new jobs in NCM communities.
  • Nexii Building Solutions Inc. (Nexii) is a green construction technology company that is committed to building a vibrant future for people and the planet.

Maison Villevert Appoints BCI as US Exclusive Importer

Retrieved on: 
Tuesday, December 14, 2021
Crus, Jean-Sébastien Robicquet, Drink, Growth, Comte, Vodka, Champagne, Pernod Ricard, Collection, List of liqueurs, Trois, GLOBE, BCI, Partnership, Bitters, Martinique, Fashion, Retail, Campari, Terroir

HOUSTON, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Continuing its impressive growth as a leading importer of Terroir spirits and beverages to the U.S. market, Texas' BCI has been named the new, exclusive importer of Maison Villevert for the United States beginning Jan. 1, 2022.

Key Points: 
  • HOUSTON, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Continuing its impressive growth as a leading importer of Terroir spirits and beverages to the U.S. market, Texas' BCI has been named the new, exclusive importer of Maison Villevert for the United States beginning Jan. 1, 2022.
  • "We are very pleased to announce this new partnership with BCI for our collection of brands of Maison Villevert starting Jan. 1,2022, in the U.S. market," says Alexandre Robicquet, North American Market Manager.
  • We have mapped out an exciting plan with BCI and will be supporting our ambition aggressively in the years to come."
  • "We are very excited to welcome the Robicquet family and Maison Villevert in our collection of terroir brands at BCI," says Jean-Francois Bonnet, founder and President of BCI.

Evolution Research Group, LLC Expands Clinical Development Capabilities and Adds Scientific Expertise

Retrieved on: 
Monday, November 8, 2021
Andria, View, Industry, CRO, Pharmaceutical Services Negotiating Committee, MD, Sleep, Neuroscience, Organization, CEO, KOL, Crus, Strategic planning, Growth, ERG, Chronic pain, NEW, Lists of diseases, Multimedia, LLC, Research, DRS, Psychiatry, Fine chemical, Pharmaceutical industry

ERG expanded its service offering to include specialized full-service CRO and rater training capabilities to satisfy increasing client demand, particularly in the early clinical development space.

Key Points: 
  • ERG expanded its service offering to include specialized full-service CRO and rater training capabilities to satisfy increasing client demand, particularly in the early clinical development space.
  • The expansion supports ERG's consistent strategy of continuously adding talent and services to further diversify within neuroscience and streamline clinical trial execution across all phases of development.
  • Ramirez has been a member of ERG's Scientific Leadership Team since its inception and along with its other members, including drug development experts Drs.
  • Evolution Research Group, LLC is a subsidiary of ERG Holding Company, which includes twenty wholly-owned and operated CRUs, an established network of affiliated clinical research sites, Lotus Clinical Research, LLC, a full-service CRO, and CNS Ratings, LLC, a rater training, surveillance and consulting company.

Bordeaux's Crus Bourgeois du Médoc set Announcement Date for New Three Tier 2020 Classification

Retrieved on: 
Monday, January 27, 2020
Wine classification, Wine, Cru Bourgeois, Bordeaux wine, Crus, Bordeaux Wine Official Classification

NEW YORK, Jan. 27, 2020 /PRNewswire-PRWeb/ --The Crus Bourgeois du Mdoc ( http://www.crubourgeois.com ), one of the oldest and most prestigious classifications in Bordeaux, will publish their new, highly anticipated three tier 2020 Crus Bourgeois du Mdoc Classification on February 2, 2020.

Key Points: 
  • NEW YORK, Jan. 27, 2020 /PRNewswire-PRWeb/ --The Crus Bourgeois du Mdoc ( http://www.crubourgeois.com ), one of the oldest and most prestigious classifications in Bordeaux, will publish their new, highly anticipated three tier 2020 Crus Bourgeois du Mdoc Classification on February 2, 2020.
  • Coinciding with the launch, the Crus Bourgeois du Mdoc will be launching a new brand identity and communication campaign that will be continued throughout the Classification.
  • The Crus Bourgeois du Mdoc ( http://www.crus-bourgeois.com ) form the largest family of Bordeaux crus from some of the most prestigious appellations of the Left Bank.
  • Thanks to its yearly blind selection process, the Crus Bourgeois du Mdoc guarantee consumers a standard of quality for every bottle that proudly bears the "Cru Bourgeois" label.

Seven Seas Water Announces Curaçao Contract Update

Retrieved on: 
Monday, July 1, 2019
Natural Resources, Energy, Other Natural Resources, Utilities, Water, Chemistry, Water desalination, Chemical elements, Desalination, Filters, Fresh Water, Water treatment, Water supply, Crus, AquaVenture, Seven Seas Water

The existing water supply agreement with CRU began in December 2008, with the Company providing water from a desalination plant with an initial design capacity of 0.5 million gallons per day under a 5-year contract.

Key Points: 
  • The existing water supply agreement with CRU began in December 2008, with the Company providing water from a desalination plant with an initial design capacity of 0.5 million gallons per day under a 5-year contract.
  • Olaf N. Krohg, Seven Seas Waters CEO, commented: We value the fruitful and constructive relationship that we have had with CRU over the last decade.
  • During this time, we have regularly increased our water production to meet CRUs water needs.
  • Seven Seas Water offers WAAS solutions by providing outsourced desalination, wastewater treatment and water reuse solutions for governmental, municipal (including utility districts), industrial, property developer and hospitality customers.